14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
May 03, 2024 Buy 30 000 Zante Greg Common Stock, par value $0.00001 per share
May 03, 2024 Sell 3 101 Zante Greg Common Stock, par value $0.00001 per share
May 03, 2024 Buy 4 249 Zante Greg Common Stock, par value $0.00001 per share
May 03, 2024 Sell 45 570 Zante Greg Common Stock, par value $0.00001 per share
May 03, 2024 Sell 17 238 Zante Greg Common Stock, par value $0.00001 per share
May 03, 2024 Sell 847 Zante Greg Common Stock, par value $0.00001 per share
May 03, 2024 Sell 30 000 Zante Greg Stock Option (Right to Buy)
May 03, 2024 Sell 4 249 Zante Greg Stock Option (Right to Buy)
May 01, 2024 Buy 51 000 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Sell 23 746 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Sell 26 142 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Buy 35 426 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Buy 90 000 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Sell 105 343 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Buy 87 000 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Buy 17 999 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Sell 119 946 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Sell 6 248 Mancini Marianna Common Stock, par value $0.00001 per share
May 01, 2024 Sell 51 000 Mancini Marianna Stock Option (Right to Buy)
May 01, 2024 Sell 87 000 Mancini Marianna Stock Option (Right to Buy)
May 01, 2024 Sell 35 426 Mancini Marianna Stock Option (Right to Buy)
May 01, 2024 Sell 17 999 Mancini Marianna Stock Option (Right to Buy)
May 01, 2024 Sell 90 000 Mancini Marianna Stock Option (Right to Buy)
Mar 27, 2024 Buy 31 667 Mancini Marianna Common Stock, par value $0.00001 per share
Mar 27, 2024 Sell 16 610 Mancini Marianna Common Stock, par value $0.00001 per share
Mar 27, 2024 Buy 221 667 Lian Brian Common Stock, par value $0.00001 per share
Mar 27, 2024 Sell 153 948 Lian Brian Common Stock, par value $0.00001 per share
Mar 27, 2024 Buy 31 667 Zante Greg Common Stock, par value $0.00001 per share
Mar 27, 2024 Sell 16 610 Zante Greg Common Stock, par value $0.00001 per share
Mar 01, 2024 Buy 221 667 Lian Brian Common Stock, par value $0.00001 per share
Mar 01, 2024 Sell 162 815 Lian Brian Common Stock, par value $0.00001 per share
Mar 01, 2024 Buy 31 667 Mancini Marianna Common Stock, par value $0.00001 per share
Mar 01, 2024 Sell 16 958 Mancini Marianna Common Stock, par value $0.00001 per share
Mar 01, 2024 Buy 31 667 Zante Greg Common Stock, par value $0.00001 per share
Mar 01, 2024 Sell 20 093 Zante Greg Common Stock, par value $0.00001 per share
Feb 09, 2024 Sell 45 000 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Buy 140 000 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 60 000 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Buy 49 079 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 49 079 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 80 000 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 40 000 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 40 000 Lian Brian Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 34 931 Lian Brian Stock Option (right to buy)
Feb 08, 2024 Sell 140 000 Lian Brian Stock Option (right to buy)
Feb 08, 2024 Buy 25 000 Rouan Sarah Kathryn Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 25 000 Rouan Sarah Kathryn Common Stock, par value $0.00001 per share
Feb 08, 2024 Sell 25 000 Rouan Sarah Kathryn Stock Option (Right to Buy)
Jan 31, 2024 Buy 85 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 31, 2024 Sell 40 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 31, 2024 Sell 45 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 31, 2024 Sell 85 000 Lian Brian Stock Option (right to buy)
Jan 30, 2024 Buy 35 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 30, 2024 Sell 35 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 30, 2024 Sell 35 000 Lian Brian Stock Option (right to buy)
Jan 19, 2024 Buy 30 000 Rouan Sarah Kathryn Common Stock, par value $0.00001 per share
Jan 19, 2024 Sell 30 000 Rouan Sarah Kathryn Stock Option (Right to Buy)
Jan 19, 2024 Sell 30 000 Rouan Sarah Kathryn Common Stock, par value $0.00001 per share
Jan 04, 2024 Sell 39 552 Lian Brian Common Stock, par value $0.00001 per share
Jan 04, 2024 Sell 14 199 Mancini Marianna Common Stock, par value $0.00001 per share
Jan 04, 2024 Sell 13 872 Zante Greg Common Stock, par value $0.00001 per share
Jan 04, 2024 Sell 15 000 Zante Greg Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 160 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 150 000 Lian Brian Common Stock, par value $0.00001 per share
Jan 03, 2024 Sell 106 115 Lian Brian Common Stock, par value $0.00001 per share
Jan 03, 2024 Sell 108 525 Lian Brian Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 360 000 Lian Brian Stock Option (Right to Buy)
Jan 03, 2024 Buy 70 000 Mancini Marianna Common Stock, par value $0.00001 per share
Jan 03, 2024 Sell 32 677 Mancini Marianna Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 28 334 Mancini Marianna Common Stock, par value $0.00001 per share
Jan 03, 2024 Sell 16 533 Mancini Marianna Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 155 000 Mancini Marianna Stock Option (Right to Buy)
Jan 03, 2024 Buy 70 000 Zante Greg Common Stock, par value $0.00001 per share
Jan 03, 2024 Sell 30 889 Zante Greg Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 28 334 Zante Greg Common Stock, par value $0.00001 per share
Jan 03, 2024 Sell 18 233 Zante Greg Common Stock, par value $0.00001 per share
Jan 03, 2024 Buy 155 000 Zante Greg Stock Option (Right to Buy)
Jan 02, 2024 Buy 32 000 Singleton J Matthew Stock Option (Right to Buy)
Jan 02, 2024 Buy 32 000 Rowland Charles A Jr Stock Option (Right to Buy)
Jan 02, 2024 Buy 32 000 Rouan Sarah Kathryn Stock Option (Right to Buy)
Jan 02, 2024 Buy 32 000 Macartney Lawson Stock Option (Right to Buy)
Jan 02, 2024 Buy 32 000 Foehr Matthew W Stock Option (Right to Buy)
May 16, 2023 Buy 40 000 Rowland Charles A Jr Common Stock, par value $0.00001 per share
May 16, 2023 Sell 40 000 Rowland Charles A Jr Common Stock, par value $0.00001 per share
May 16, 2023 Sell 40 000 Rowland Charles A Jr Stock Option (Right to Buy)
May 16, 2023 Buy 16 000 Macartney Lawson Common Stock, par value $0.00001 per share
May 16, 2023 Sell 16 000 Macartney Lawson Common Stock, par value $0.00001 per share
May 16, 2023 Sell 16 000 Macartney Lawson Stock Option (Right to Buy)
May 01, 2023 Sell 45 000 Lian Brian Common Stock, par value $0.00001 per share
Apr 24, 2023 Buy 16 000 Macartney Lawson Common Stock, par value $0.00001 per share
Apr 24, 2023 Sell 16 000 Macartney Lawson Common Stock, par value $0.00001 per share
Apr 24, 2023 Sell 16 000 Macartney Lawson Stock Option (Right to Buy)
Apr 19, 2023 Sell 35 000 Lian Brian Common Stock, par value $0.00001 per share
Apr 17, 2023 Buy 20 786 Macartney Lawson Common Stock, par value $0.00001 per share
Apr 17, 2023 Sell 20 786 Macartney Lawson Common Stock, par value $0.00001 per share
Apr 17, 2023 Sell 20 786 Macartney Lawson Stock Option (Right to Buy)
Apr 17, 2023 Buy 125 000 Lian Brian Common Stock, par value $0.00001 per share
Apr 17, 2023 Sell 155 000 Lian Brian Common Stock, par value $0.00001 per share
Apr 17, 2023 Sell 125 000 Lian Brian Stock Option (Right to Buy)
Apr 17, 2023 Buy 12 500 Mancini Marianna Common Stock, par value $0.00001 per share
INSIDER POWER
0.747
Last 100 transactions
Buy: 2 816 709 | Sell: 2 831 066 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.747.

In total, the insiders bought 2 816 709 and sold 2 831 066 VKTX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Viking Therapeutics

Viking Therapeutics Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev... VKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT